home / stock / bwv / bwv news


BWV News and Press, Blue Water Vaccines Inc.

Stock Information

Company Name: Blue Water Vaccines Inc.
Stock Symbol: BWV
Market: NASDAQ

Menu

BWV BWV Quote BWV Short BWV News BWV Articles BWV Message Board
Get BWV Alerts

News, Short Squeeze, Breakout and More Instantly...

BWV - Onconetix(TM) Chief Executive Officer Dr. Neil J. Campbell Issues Letter to Shareholders

CINCINNATI, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Onconetix, Inc., (Nasdaq: BWV) ("Onconetix" or the “Company”) today issued the following shareholder letter from the Company’s Chief Executive Officer, Dr. Neil Campbell. To Our Valued Shareholders, As 2023 draws to a cl...

BWV - Blue Water Biotech Acquires Proteomedix as Part of Transformation to Commercial Stage Oncology Company; Announces Name Change to Onconetix(TM)

CINCINNATI, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (Nasdaq: BWV) ("BWB" or the “Company”) today announced the acquisition of Proteomedix AG, a private, commercial-stage diagnostics oncology company (the “Transaction”), and introduced a new name for ...

BWV - Expected US Company Earnings on Thursday, November 16th, 2023

thyssenkrupp AG (TYEKF) is expected to report for Q4 2023 Azul S.A. American Depositary Shares (each representing three preferred shares) (AZUL) is expected to report $-0.38 for Q3 2023 Bath & Body Works Inc. (BBWI) is expected to report $0.36 for Q3 2024 Johnson Controls Internat...

BWV - Expected US Company Earnings on Thursday, November 9th, 2023

Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...

BWV - Blue Water to acquire a commercial stage oncology company

2023-11-02 07:20:02 ET More on Blue Water Vaccines Seeking Alpha’s Quant Rating on Blue Water Vaccines Historical earnings data for Blue Water Vaccines Financial information for Blue Water Vaccines For further details see: Blue Water to acquire ...

BWV - Blue Water Biotech Signs Non-Binding Term Sheet to Acquire a Commercial Stage Oncology Company

CINCINNATI, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (Nasdaq: BWV) ("BWB" or the “Company”), today announced the execution of a non-binding term sheet regarding the acquisition of a private commercial stage oncology biotechnology company (the “Proposed Trans...

BWV - Blue Water Biotech Announces It Has Regained Compliance with Nasdaq Listing Rule 5250(c)(1)

CINCINNATI, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (Nasdaq: BWV) ("BWB" or the “Company”) today announced that it has received a letter from the Nasdaq Stock Market, LLC ("Nasdaq") stating that the Company has regained compliance with the Nasdaq Stock Market, LLC...

BWV - Blue Water Biotech Issues Letter to Shareholders

CINCINNATI, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (Nasdaq: BWV) ("BWB" or the “Company”) today issued the following shareholder letter from the Company’s Chief Executive Officer Dr. Neil Campbell. Dear Shareholders, As we close out October and t...

BWV - Large Vs. Small Gap Keeps Widening

2023-10-25 20:35:00 ET Summary With each passing day this year, it seems as though the underperformance of small caps relative to large caps keeps getting wider. While the small-cap Russell 2000 is currently down over 30% from its post-Covid highs and within 1% of a multi-year low...

BWV - Expanding (Investment) Horizons: The Case For Investing Globally

2023-10-19 23:00:00 ET Summary U.S. equities have ruled the roost for the better part of the last decade, but another region may emerge as the leader if the business cycle changes. The decision to allocate investments between the U.S. and international markets is not a binary choi...

Next 10